Librería: Phatpocket Limited, Waltham Abbey, HERTS, Reino Unido
EUR 66,16
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Librería: KCMidwestbooks, Leawood, KS, Estados Unidos de America
EUR 72,37
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: New. Book is n new condition. Pages are clean, crisp, free from markings and unread.
EUR 102,74
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
EUR 17,98
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Sehr gut. Zustand: Sehr gut | Seiten: 448 | Sprache: Englisch | Produktart: Bücher | Neuroscience's inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book's premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo gists and chemists, and clinicians. The chapters describe the status of the existing disease treat ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 164,57
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
EUR 136,16
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
EUR 136,16
Cantidad disponible: Más de 20 disponibles
Añadir al carritoGebunden. Condición: New.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 191,47
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
EUR 197,56
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. Series: Contemporary Neuroscience. Num Pages: 434 pages, biography. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 23. Weight in Grams: 652. . 2013. Softcover reprint of the original 1st ed. 1996. Paperback. . . . .
EUR 204,46
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. This text aims to assist basic neuroscientists, industry-based pharmacologists, and chemists and clinicians in developing new and better drugs to treat neurological diseases. Each chapter examines a neurological disease, including clinical features and existing treatments. Series: Contemporary Neuroscience. Num Pages: 434 pages, biography. BIC Classification: MJN; MMG; PSAN. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 227 x 152 x 28. Weight in Grams: 825. . 1995. Hardback. . . . .
EUR 239,59
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. 444 pages. 9.02x5.98x1.06 inches. In Stock.
EUR 251,19
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. Series: Contemporary Neuroscience. Num Pages: 434 pages, biography. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 23. Weight in Grams: 652. . 2013. Softcover reprint of the original 1st ed. 1996. Paperback. . . . . Books ship from the US and Ireland.
EUR 260,01
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New. This text aims to assist basic neuroscientists, industry-based pharmacologists, and chemists and clinicians in developing new and better drugs to treat neurological diseases. Each chapter examines a neurological disease, including clinical features and existing treatments. Series: Contemporary Neuroscience. Num Pages: 434 pages, biography. BIC Classification: MJN; MMG; PSAN. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 227 x 152 x 28. Weight in Grams: 825. . 1995. Hardback. . . . . Books ship from the US and Ireland.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 126,26
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 160,49
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Neuroscience's inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book's premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo gists and chemists, and clinicians. The chapters describe the status of the existing disease treat ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves. 448 pp. Englisch.
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Neuroscience's inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book's premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo gists and chemists, and clinicians. The chapters describe the status of the existing disease treat ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 448 pp. Englisch.